Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility

NCT02889341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-02

No results posted yet for this study

Summary

Sperm parameters will be examined before DHA (DHA=Docosahexanoic Acid) consumption, after one months and after 2 months taken Docosahexanoic Acid or placebo.

Conditions

  • Male Infertility

Interventions

DIETARY_SUPPLEMENT

DHA

OTHER

Placebo

Sponsors & Collaborators

  • Vida Recoletas Sevilla

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-22
Primary Completion
2015-05-26
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02889341 on ClinicalTrials.gov